newsfilter
← Latest News
GlobeNewswire·

ArriVent Announces Pricing of Upsized Initial Public Offering

NEWTOWN SQUARE, Pa., Jan. 25, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. ("ArriVent") (NASDAQ:AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical